Jan 22–25, 2024 | Santa Fe Community Convention Center, Santa Fe, NM, United States
Scientific Organizers:
Dan S. Kaufman, Kiem, and Sonja Schrepfer

-
Scientific Organizers: Dan S. Kaufman, Kiem, and Sonja Schrepfer
Dan S. Kaufman
Kiem
Sonja Schrepfer
***Meeting program subject to change.
Available Formats: = In Person = On DemandMerchandise Options
Registration Options
Booking Function
Fundraising
Monday, January 22, 2024
Tuesday, January 23, 2024
In vivo LNP-mRNA Therapies
in vivo Reprogramming for Rejuvenation
Programming Novel Cancer Therapeutics
Cell and Gene Therapy for Retinal Regeneration
Short Talk: Short Talk: Injectable and Modular Multicellular Liver Tissue Engineering
Short Talk: Short Talk: Allogeneic Regenerative Cell Therapy for White Matter Stroke and Vascular Dementia
Chief Scientific Officer
ICREA Research Professor and Senior Scientist
Professor
Assistant Professor
Therapeutic Genome Editing of Hematopoietic Stem Cells for the Treatment of Sickle Cell Disease
Genome Edited B Cells for Custom Antibody Production
New Approaches for Cell Therapy Against Malignant and Infectious Disease
Short Talk: Short Talk: ORN-101 isCAR Therapy for the Treatment of B Cell Malignancies
Short Talk: Short Talk: Development of an Ex Vivo Precision Gene Engineered B Cell Medicine Platform that Produces Active and Sustained Levels of Therapeutic Proteins with Broad Utility in Rare Diseases and Cancer
Wednesday, January 24, 2024
Production of Immune Privileged iPSCs
iPSC-Derived Treatment for Parkinson's Disease
NRTX-1001 - A Human Pluripotent Stem Cell-Derived Inhibitory Interneuron Cell Therapy For Drug-Refractory Focal Epilepsy: From Preclinical Characterization To First Clinical Trial Results
Discovering Therapies for the CVD using hiPSC
Short Talk: Short Talk: Engraftment and Injury Repair in Regionally Conditioned Rat Lung in vivo by Lung Progenitors Derived from Human Pluripotent Stem Cells
Short Talk: Short Talk: Nanowired Human Cardiac Organoid Transplantation Enables Highly Efficient and Effective Recovery of Infarcted Hearts
Biomaterial-enabled Macrophage Cell Therapy for Regenerative Medicine
Generation and Characterization of ‘Universal’ Low-Immunogenic Human Primary Cholangiocyte Organoids for Treatment of Bile Duct Disorders
Programmable Synthetic GPCRs for Customized Antigen-dependent Control of Cell Behaviors
Myeloid Blasts Induce an Irreversible Epigenetic Scar in NK Cells Leading to a Global Dysfunction
One-step Enrichment of Cells with Multi-locus Knockins through SEED-Selection
Autonomous T Cell Activation-inducible mRNA Switches for Enhanced Cell Therapy
Novel Chimeric Antigen Receptors for In Vivo Programing of Immune Cells to Target Cancer
Engineered iPSC-Derived Immune Cells for Improved Cancer Therapies
Clinical Translation of Engineered NK Cell-Based Therapies
Novel Targets for CAR-T Cell-Based Therapy
Short Talk: Short Talk: Allogeneic NKT Cells Expressing a CD19-specific CAR in Patients with Relapsed or Refractory B Cell Malignancies: An Interim Analysis
Short Talk: Short Talk: Identification of Novel, Recurrent Tumor-specific Targets for Next-generation Cancer Immunotherapies
Thursday, January 25, 2024
Remote Presentation: Mechanisms that Regulate NK Cell Anti-Viral Activity
Short Talk: Short Talk: Prophylactic and Long-lasting Efficacy of Senolytic CAR T Cells Against Age-related Phenotypes
CD19 CAR-T Cells for the Treatment of Autoimmune Disease
Anti-Viral Cell Therapy
Short Talk: Short Talk: Developing CAR-NK Cells Against Severe Acute Respiratory Syndrome Coronavirus 2 for Immunocompromised Individuals
Metabolic and Stress Regulation of HSCs
Mechanistic Insights to Advance HSC-Based Gene and Cell Therapies
HSC Gene Therapy for Immunodeficiencies
Friday, January 26, 2024
Subscribe for Updates